Upcoming aditxt weekly update to feature dr. shahrokh shabahang, chief innovation officer (cio) of aditxt™, and dr. friedrich kapp, co-ceo of adimune™, to discuss progress of lead therapeutic candidate adi-100™

Mountain view, calif.--(business wire)--aditxt, inc. (nasdaq: adtx) ("aditxt" or the "company"), a social innovation platform accelerating promising health innovations, announced that aditxt's cio dr. shahrokh shabahang, and adimune's co-ceo dr. friedrich kapp, will join today's aditxt weekly update to discuss recent developments related to adi-100™, the lead therapeutic candidate of its wholly owned subsidiary, adimune. event details: title: aditxt weekly update date: friday, may 2, 2025 time:.
CIO Ratings Summary
CIO Quant Ranking